[
  {
    "question": "Most common type of aura in MTL seizure?\nI don\u2019t remember the choices.",
    "option_a": "). Other potential options (olfactory, visual, somatosensory, or auditory auras) are less common in MTL epilepsy, making the epigastric sensation the typical and most frequently encountered aura.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Auras represent the initial subjective symptoms of a seizure. In mesial temporal lobe (MTL) epilepsy, the most commonly reported aura is an epigastric rising sensation. This sensation often heralds an impending complex partial seizure. The epigastric aura is believed to result from abnormal activation of the limbic structures including the insular cortex, amygdala, and hippocampus. These regions are involved in visceral sensation and emotional regulation, leading to the characteristic rising feeling in the stomach. Patients with mesial temporal lobe seizures often experience this epigastric aura before losing awareness and developing automatisms. It is a valuable clinical clue when localizing the onset of seizure activity to the mesial temporal region. A detailed history of the aura is essential. Differential diagnoses include panic attacks and gastrointestinal disturbances; however, the stereotyped and recurrent nature of the aura, along with its progression to other seizure manifestations, differentiates it from these conditions. EEG and neuroimaging further help confirm the mesial temporal origin. Recognition of the aura can assist in the overall management plan. In drug-resistant cases, surgical resection targeting the mesial temporal structures is considered. For pregnant or lactating patients, careful AED selection is critical to minimize fetal risks, and the precise localization provided by typical auras aids in optimizing therapy while potentially reducing medication load. The analysis provided indicates that the correct option is the epigastric rising sensation (marked as Option A). Other potential options (olfactory, visual, somatosensory, or auditory auras) are less common in MTL epilepsy, making the epigastric sensation the typical and most frequently encountered aura. 1. An epigastric rising sensation is the hallmark aura in mesial temporal lobe epilepsy. 2. The aura helps to lateralize the seizure focus and differentiate MTL epilepsy from other focal epilepsies. 3. A consistent aura improves the accuracy of surgical planning in drug-resistant cases. Multiple clinical studies and current guidelines have validated the epigastric rising sensation as the most common aura in MTL epilepsy. Contemporary research continues to refine our understanding of seizure semiology, which is crucial for accurate localization and management decisions, particularly in surgical candidates.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Young patinet has tic and seizure, MRI showed diffuse high signal intensity, how to make the Dx",
    "option_a": "Skin Biopsy",
    "option_b": "Muscle biopsy",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "This question is suggestive of a young patient with neurologic manifestations (tics \u2013 likely meant to represent myoclonic jerks \u2013 and seizures) accompanied by diffuse high signal intensity on MRI. Such a presentation is classically seen in mitochondrial disorders such as MERRF (Myoclonic Epilepsy with Ragged Red Fibers), where the definitive diagnostic test is a muscle biopsy. MERRF is a mitochondrial cytopathy caused by mutations in the mitochondrial DNA. Defective oxidative phosphorylation leads to energy failure in high-demand tissues like muscle and brain. The muscle biopsy in these patients typically demonstrates ragged red fibers (accumulation of abnormal mitochondria in the muscle fiber periphery) and cytochrome c oxidase\u2013negative fibers, which is diagnostic of a mitochondrial myopathy. The clinical picture of seizures (often with myoclonic jerks), movement disorders, and diffuse brain MRI changes fits with mitochondrial encephalopathy. The association of these neurological findings with characteristic histological findings on muscle biopsy offers a direct link between clinical manifestations and the underlying mitochondrial dysfunction. In suspected mitochondrial diseases, the work\u2010up includes neuroimaging (MRI can show high\u2010signal lesions due to metabolic injury), measurement of serum lactate levels, and ultimately, muscle biopsy to reveal ragged red fibers. Differential diagnoses include other neurodegenerative or metabolic disorders. Genetic testing may also be used to identify specific mutations; however, muscle biopsy remains a key diagnostic tool. Management is largely supportive. First\u2010line therapy includes appropriate antiepileptic agents (avoiding drugs such as valproate that may worsen mitochondrial toxicity) and supportive measures including mitochondrial cocktails (coenzyme Q10, L-carnitine, and antioxidants). There is no cure; treatment is aimed at symptom control and supportive care. In pregnancy and lactation, careful selection of AEDs (preferring those with better safety profiles) and close multidisciplinary monitoring is required, as metabolic demands and potential teratogenic risks must be balanced. Option A (Skin Biopsy) is incorrect because skin biopsies are typically used in the work-up of neurocutaneous disorders rather than mitochondrial diseases. Option B (Muscle Biopsy) is correct because it is essential for demonstrating the histologic changes of mitochondrial myopathies (ragged red fibers). Options C and D are not provided or relevant in this context. 1. MERRF syndrome presents with myoclonic seizures and is diagnosed by identifying ragged red fibers on muscle biopsy. 2. Diffuse high signal intensity on MRI can reflect metabolic injury in mitochondrial disorders. 3. Muscle biopsy remains a gold standard tool for diagnosis amid the rising role of genetic testing. Recent research underscores the importance of combining histopathology with molecular genetic testing for mitochondrial disorders. While advances in genetic diagnostics are growing, the muscle biopsy still plays a crucial role when clinical suspicion is high, and guidelines continue to recommend it as part of the diagnostic algorithm for conditions like MERRF.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Young patinet has tic and seizure, MRI showed diffuse high signal intensity, how to make the Dx?",
    "option_a": "Skin Biopsy",
    "option_b": "Muscle biopsy",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "This question is identical to MCQ ID 99991008 and revolves around a young patient with movement abnormalities (the term 'tic' here likely represents myoclonic jerks) and seizures, alongside diffuse high signal intensity on MRI. The finding points toward a mitochondrial disorder such as MERRF, making muscle biopsy the investigation of choice. MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is caused by mutations in mitochondrial DNA that disrupt energy production. This leads to the accumulation of abnormal mitochondria in muscle fibers, which on biopsy are seen as ragged red fibers, correlating with the clinical neurological symptoms. The constellation of myoclonic seizures, other movement disorders, and diffuse brain changes is typical for mitochondrial encephalopathy. The physical evidence on muscle biopsy directly supports the clinical diagnosis by revealing mitochondrial dysfunction. After neuroimaging and laboratory evaluations (including lactate levels), muscle biopsy is performed to detect histological changes typical of mitochondrial myopathies. Differential considerations could include other metabolic or neurodegenerative disorders; however, the biopsy findings are specific for mitochondrial disease. Management involves symptomatic treatment: selecting appropriate antiepileptic medications (while avoiding mitochondrial-toxic drugs such as valproate), supportive care, and supplementation with mitochondrial cofactors. In pregnant or lactating patients, careful drug selection and monitoring are vital to balance maternal treatment and fetal/neonatal safety. Option A (Skin Biopsy) is inappropriate since skin biopsy is not diagnostic for mitochondrial disorders. Option B (Muscle Biopsy) is correct because it reveals the histopathological changes (ragged red fibers) seen in mitochondrial myopathies. Options C and D are not applicable based on the provided information. 1. In suspected MERRF syndrome, muscle biopsy showing ragged red fibers is diagnostic. 2. Mitochondrial disorders have a multisystem presentation and require a high index of suspicion. 3. Avoid AEDs that impair mitochondrial function in these patients. Current guidelines and studies continue to support the use of muscle biopsy, along with genetic testing, in the diagnosis of mitochondrial disorders. Advances in molecular diagnostics are promising, however, histologic examination remains a reliable and established method.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "A pharmacy company who did the clinical trial for a new AED, ask you to give presentation and they will give you sponsor for international flights and international conferences. What you will do.",
    "option_a": "Disclose this in the presentation.",
    "option_b": "Refuse the offer.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question addresses the ethical management of conflict of interest in academic presentations. It deals with the scenario where a pharmaceutical company, after sponsoring a clinical trial on a new AED, offers to cover international travel and conference expenses in exchange for a presentation. While there is no biological pathophysiology in this scenario, the underlying ethical principles revolve around maintaining integrity and transparency in clinical practice and research presentation. In clinical practice, conflicts of interest must be managed carefully to avoid biasing research findings and clinical recommendations. Transparency in disclosing any financial or sponsorship relationships helps maintain trust between clinicians, audiences, and patients. Not applicable in this ethical scenario. Instead, it requires an ethical analysis based on guidelines from organizations such as the ICMJE and the American Medical Association. According to current ethical guidelines, any potential conflicts of interest must be fully disclosed during presentations or publications. First-line ethical management is transparency. If the relationship seems likely to compromise objectivity, further measures (such as recusal or refusing the offer) might be indicated. For pregnant or lactating clinicians, the ethical guidelines remain the same: maintain transparency and avoid any undue influence on clinical decision-making. Option A (Disclose this in the presentation) is correct because full disclosure is the recommended ethical approach to managing potential conflicts of interest. Option B (Refuse the offer) might be considered in cases where the sponsorship is excessively coercive or could compromise academic independence, but when the sponsorship is ethical and disclosure is complete, acceptance with clear disclosure is acceptable. Options C and D are not presented. 1. Always disclose any potential conflicts of interest to maintain credibility. 2. Transparency is key in safeguarding the integrity of scientific communications. 3. Ethical guidelines from bodies like the ICMJE mandate full disclosure of sponsorships or financial ties. Recent updates from the International Committee of Medical Journal Editors (ICMJE) and other regulatory bodies emphasize mandatory disclosure of all funding sources to counter potential biases. Academic institutions also reinforce these policies in educational settings.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "A chid who has 2 episodes of seizure, all when he was in the train, associated with nausea and vomitng. EEG showed posterior discharges, What\u2019s the Dx?",
    "option_a": "occipital seizure.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question presents a child with two episodes of seizures that occur specifically when riding on a train. The episodes are accompanied by nausea and vomiting, and the EEG reveals posterior (occipital) discharges. Such a clinical picture is most consistent with seizures originating from the occipital lobe. Occipital lobe seizures, particularly in children, may present with visual disturbances and autonomic symptoms including nausea and vomiting. In many cases, this presentation is associated with a benign epilepsy syndrome such as Panayiotopoulos syndrome, where autonomic features predominate and EEG abnormalities are often noted in the posterior regions. Children with occipital lobe epilepsy may experience episodes with prominent autonomic symptoms like nausea and vomiting. Triggers such as the sensory experiences on a moving train can precipitate seizures in susceptible individuals. The EEG finding of posterior discharges supports the localization to the occipital lobe. The diagnostic approach involves a detailed history (noting triggers and associated autonomic symptoms), a thorough neurological exam, and an EEG to assess the seizure focus. Differential diagnoses include syncope (which typically lacks EEG changes), migraine with aura, and other focal epilepsies. The combination of autonomic symptoms with EEG evidence of occipital discharges strongly favors an occipital lobe seizure, often seen in syndromes like Panayiotopoulos syndrome. Management is generally conservative given the benign nature of the syndrome. First-line treatment involves the use of appropriate antiepileptic drugs (AEDs) tailored to the seizure type. Given the typical benign course of conditions such as Panayiotopoulos syndrome, long-term medication may not always be necessary. In pregnant or lactating patients (or in future considerations as the child matures), drug selection should prioritize safety profiles, with drugs like levetiracetam often preferred. Option A (occipital seizure) is marked as the answer and is correct in that it identifies the likely epileptogenic zone in this patient. Although the specific pediatric epilepsy syndrome (Panayiotopoulos syndrome) is more descriptive, the option 'occipital seizure' appropriately reflects the localization suggested by the clinical scenario and EEG findings. Other options (not provided) would likely include diagnoses that do not explain the occipital discharges and autonomic features. 1. Occipital lobe seizures in children can present with prominent autonomic symptoms such as nausea and vomiting. 2. Panayiotopoulos syndrome is a benign childhood epilepsy syndrome that often presents with these features and has characteristic EEG findings. 3. Environmental triggers, like the visual stimuli in a train, can precipitate seizures in susceptible children. Recent literature emphasizes that benign childhood occipital epilepsies, particularly Panayiotopoulos syndrome, are best recognized by their autonomic features and EEG posterior discharges. Although the term 'occipital seizure' is a broad descriptor, current guidelines support this localization and note that management is generally conservative, with careful AED selection when treatment is indicated.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient presented with hallucination and followed by headache:",
    "option_a": "Occipital seizure.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Occipital seizures are focal epileptic events originating in the occipital cortex that classically produce visual symptoms such as simple, elementary visual hallucinations. These seizure events are brief, paroxysmal disruptions of normal brain activity and can be followed by a headache in the postictal period. The occipital cortex\u2019s increased excitability leads to abnormal electrical discharges, which manifest as visual hallucinations. After the seizure ends, neuronal exhaustion and the recovery process can trigger a postictal headache. This pattern distinguishes occipital seizures from other conditions with similar visual disturbances. Patients with occipital seizures typically report brief, stereotyped visual phenomena (colors, shapes, flashing lights) that may progress abruptly and are often followed by headache. Differentiating these from migraine auras is key, as migraine auras usually have a more gradual onset and evolution. The workup includes electroencephalography (EEG) to look for occipital epileptiform discharges and neuroimaging (MRI or CT) to rule out structural lesions. Differential diagnoses include migraine with aura, transient ischemic attacks, and other causes of visual disturbances. First-line treatment involves antiepileptic drugs (AEDs) such as levetiracetam, lamotrigine, or carbamazepine. In pregnant patients or those planning pregnancy, lamotrigine or levetiracetam are preferred due to their lower teratogenic risks, and folic acid supplementation is recommended. Second-line options are considered if first-line agents are ineffective or contraindicated. Option A (\u2018Occipital seizure\u2019) is correct because the described clinical picture (visual hallucination followed by headache) is classic for an occipital seizure with a postictal headache. Other options\u2014if they had included migraine with aura or other etiologies\u2014would not fit as neatly with the sudden, stereotypical hallucinations seen in focal occipital seizures. 1) Visual hallucinations in occipital seizures are usually brief, stereotyped, and followed by a headache. 2) EEG is crucial for distinguishing occipital seizures from migraine aura. 3) Early recognition and differentiation are essential for appropriate AED selection. Recent studies and updated guidelines emphasize the importance of differentiating occipital seizures from migraine aura using detailed clinical history and EEG findings, as the management differs substantially. Ongoing research into the cortical excitability in epilepsy supports the use of specific AEDs that target the underlying neuronal hyperexcitability.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with GTC with interictal myoclonus (typical scenario for JME) what is the mechanism:",
    "option_a": "GABA A mutation.",
    "option_b": "Ion Channel.",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "Juvenile Myoclonic Epilepsy (JME) is a common form of idiopathic generalized epilepsy that typically presents during adolescence. It is characterized by a combination of generalized tonic\u2010clonic seizures (GTC), myoclonic jerks (often interictal), and sometimes absences. JME is considered a channelopathy, with genetic predispositions affecting ion channel function. Multiple genes have been implicated, and many affect ion channels \u2013 including calcium, sodium, and potassium channels \u2013 leading to neuronal hyperexcitability. While mutations affecting GABA-A receptors have been noted in some epilepsies, JME is more broadly linked to overall ion channel dysfunction. The classic presentation of JME includes generalized tonic-clonic seizures combined with interictal myoclonus, typically occurring shortly after awakening. Factors like sleep deprivation, stress, or photic stimulation may exacerbate seizures. The diagnosis is supported by a characteristic EEG pattern with generalized polyspike and slow-wave discharges. Differential diagnoses include other forms of generalized epilepsy (such as absence epilepsy) and symptomatic myoclonic disorders; careful clinical history and EEG findings help clarify the diagnosis. First-line treatment for JME typically includes valproate, which is highly effective. Alternative medications include levetiracetam and lamotrigine, although these must be selected carefully in women of childbearing potential due to teratogenic risks. A tiered approach involves initiating treatment, then monitoring efficacy and side effects, and adjusting as needed. Option B (\u2018Ion Channel\u2019) is correct because JME\u2019s pathophysiology is linked to dysfunction in ion channel activity. Option A (\u2018GABA A mutation\u2019) is too narrow and not representative of the broader spectrum of ion channel abnormalities seen in JME. 1) JME usually presents in adolescence with a triad of myoclonic jerks, GTC seizures, and sometimes absence seizures. 2) EEG shows characteristic generalized polyspikes. 3) JME is typically a lifelong condition requiring long-term management. Recent genetic studies and epilepsy guidelines underscore the importance of ion channel dysfunction in JME, confirming its classification as a channelopathy. Updated treatment guidelines stress individualized therapy choices, especially in populations like women of childbearing age.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Alcoholic patient came with post traumatic seizure and delerium he was on keppra and depakin then seizure improved; after 2 days the patient had worsen of his delerium; what you will do?",
    "option_a": "Alcohol level",
    "option_b": "Toxicology screening",
    "option_c": "Ammonia",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Epilepsy",
    "explanation": "In patients with epilepsy who are on antiepileptic drugs like valproate (depakin), certain adverse drug effects can occur. One recognized complication is hyperammonemia, which can lead to worsening encephalopathy and delirium, especially in vulnerable populations such as alcoholics. Valproate interferes with mitochondrial function and the urea cycle, leading to an accumulation of ammonia in the blood. Elevated ammonia levels can impair cerebral function and provoke symptoms such as confusion, lethargy, and delirium. In this clinical scenario, an alcoholic patient who initially improved with seizure control later developed worsening delirium. Given the known adverse effect of valproate-induced hyperammonemia, the clinical deterioration strongly suggests this complication rather than a recurrence of seizures or alcohol withdrawal. The appropriate evaluation includes measuring serum ammonia levels to assess for hyperammonemia. Other labs, like liver function tests, support the workup. Differential diagnoses include alcohol withdrawal, hepatic encephalopathy, and other toxic/metabolic encephalopathies. A careful timeline and medication history help distinguish these causes. Management involves promptly identifying the elevated ammonia levels and addressing the underlying cause. This may include dose reduction or discontinuation of valproate, administration of ammonia-lowering agents like lactulose, and supportive care. In pregnant or lactating patients, careful consideration of medication adjustments and close monitoring is needed to balance seizure control and drug side effects. Option C (\u2018Ammonia\u2019) is correct as it directly addresses the suspected complication of valproate-induced hyperammonemia. While checking alcohol levels or a broader toxicology screen (Options A and B) may be useful in other contexts, the clinical scenario \u2013 worsening delirium in a patient on valproate \u2013 points most convincingly to hyperammonemia. 1) Valproate can cause hyperammonemia even in patients with normal liver function tests. 2) Worsening delirium in a patient on valproate should prompt immediate evaluation of ammonia levels. 3) Early detection and management can prevent further neurological compromise. Recent guidelines and research have highlighted the importance of monitoring ammonia levels in patients treated with valproate, particularly in those presenting with altered mental status. Studies have also evaluated the role of L-carnitine supplementation in managing valproate-induced hyperammonemia.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Typical JME on topiramate and well controlled, he wants to stop the medication?",
    "option_a": "lifelong treatment",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Juvenile Myoclonic Epilepsy (JME) is a lifelong epileptic syndrome characterized by myoclonic jerks, generalized tonic-clonic seizures, and sometimes absence seizures. Even when seizures are well controlled on medications like topiramate, the underlying predisposition for seizures persists. JME is thought to be a genetic channelopathy, meaning that abnormal ion channel function predisposes patients to recurrent seizures. Despite good seizure control, the neurobiological substrate remains, which is why discontinuation often leads to relapse. Patients with JME have a high relapse risk if antiepileptic drugs are stopped, even after a long period of seizure freedom. This is why lifelong therapy is generally recommended once the diagnosis is made. The diagnosis of JME is supported by clinical history and characteristic EEG findings (generalized 4-6 Hz polyspike-slow wave discharges). Differential diagnoses include other generalized epilepsies and conditions with myoclonic jerks; however, the typical age of onset and EEG pattern solidify the diagnosis of JME. Management of JME requires long-term\u2014or lifelong\u2014antiseizure medication. The first-line treatment is typically valproate, although alternatives like levetiracetam, lamotrigine, or topiramate may be used based on individual patient factors, especially in women of childbearing potential. Given the high relapse rate after withdrawal, current guidelines recommend maintaining treatment even during prolonged periods of seizure control. In pregnancy and lactation, medication choice requires balancing seizure control with teratogenic risk, favoring agents with lower risk profiles and proper counseling. Option A (\u2018lifelong treatment\u2019) is correct because patients with JME typically require continuous therapy due to a high risk of seizure recurrence upon discontinuation. Stopping treatment in well-controlled JME is associated with a significant risk of relapse. 1) JME is generally a lifelong condition, and withdrawal of treatment often leads to seizure recurrence. 2) EEG findings in JME are characteristic and aid in diagnosis. 3) Patient counseling should emphasize the risks of discontinuing therapy. Recent clinical guidelines reaffirm that JME is a chronic condition requiring sustained treatment to prevent relapse. Ongoing research continues to evaluate the optimal long-term management strategies and safe medication profiles for patients, especially for those who are pregnant or planning pregnancy.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient came with focal seizure with secondary generalization, he has focal atrophy in the brain; what is the antibody came with this disease?",
    "option_a": "GluR3",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question points to a syndrome in which focal seizures with secondary generalization occur along with imaging evidence of focal brain atrophy. Rasmussen encephalitis is a classic example where a unilateral hemispheric atrophy is seen, and historically, the anti\u2010GluR3 (glutamate receptor 3) antibody has been implicated in its pathogenesis. Rasmussen encephalitis is believed to be an immune\u2010mediated process. Autoimmune attack, including antibodies against the GluR3 subunit of the AMPA receptor, and cytotoxic T-cell responses, result in progressive neuronal loss and inflammation localized to one hemisphere. This leads to cortical atrophy and a cascade of hyperexcitability giving rise to focal seizures that can secondarily generalize. Clinically, patients (often children) present with refractory focal seizures that may generalize, progressive neurological deficits (such as hemiparesis), and cognitive decline. The presence of focal atrophy on imaging supports the diagnosis and correlates with the disease\u2019s progressive nature. Diagnosis involves neuroimaging (MRI) showing unilateral cortical atrophy, EEG demonstrating focal epileptiform activity, and sometimes the detection of anti\u2010GluR3 antibodies in serum/CSF. Differential diagnoses include focal cortical dysplasia, post\u2010stroke epilepsy, or neoplastic lesions causing focal seizures. The clinical history, imaging studies, and sometimes immunological assays help differentiate these conditions. Management is challenging and includes a combination of antiepileptic drugs (AEDs) and immunomodulatory therapies (high-dose corticosteroids, intravenous immunoglobulins, or plasmapheresis). In refractory cases, surgical interventions, such as functional hemispherectomy, may be considered. In the context of pregnancy or lactation, the use of immunomodulatory agents requires careful risk\u2010benefit analysis and consultation with maternal\u2013fetal medicine, while AEDs should be chosen based on the safety profile during pregnancy. Option A (GluR3) is correct because anti\u2010GluR3 antibodies have been associated with Rasmussen encephalitis. The other options were not provided, but historically, GluR3 has been the recognized antibody in this syndrome. 1. Rasmussen encephalitis typically presents unilaterally with intractable focal seizures and progressive neurological deficits. 2. The detection of anti\u2010GluR3 antibodies, though not universally present, supports an autoimmune etiology. 3. Early recognition is crucial as surgical intervention (hemispherectomy) may be life\u2010changing in refractory cases. Recent research has nuanced the understanding of antibody involvement; while anti\u2010GluR3 was historically emphasized, the overall autoimmune milieu in Rasmussen encephalitis is complex. Nonetheless, anti\u2010GluR3 remains a recognized marker and guides immunomodulatory treatment strategies according to updated consensus guidelines.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with GTC seizure, what increase the recurrence of seizure:",
    "option_a": "long duration.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question is concerned with identifying factors that predispose a patient (who experienced a generalized tonic\u2010clonic seizure) to a higher risk of subsequent seizure recurrence. Understanding these prognostic factors is key in managing epilepsy. Longer seizures can cause increased neuronal stress and potentially promote a \u2018kindling\u2019 phenomenon \u2013 a process where repeated seizures enhance neuronal excitability and lower the threshold for future seizure activity. Prolonged seizure activity may also result in greater neuronal injury, rendering the brain more susceptible to additional events. Clinically, patients who experience longer seizure durations may have more severe underlying epileptogenic processes. This phenomenon can translate into more frequent or recurrent seizures over time. Detailed history taking regarding the duration and severity of seizures is essential in prognostication. Evaluating risk factors for recurrence involves a careful review of the seizure history, duration of each episode, EEG findings, and neuroimaging studies to rule out structural lesions. Differential diagnoses for recurrent seizures include noncompliance with medication, metabolic disturbances, or secondary epilepsy due to structural brain changes. Risk reduction strategies involve optimizing AED therapy, reassuring patient adherence, and mitigating modifiable risk factors such as sleep deprivation or metabolic imbalances. In pregnant or lactating women, AED selection and dosing require extra caution; medications with favorable safety profiles should be chosen, and serum levels monitored closely throughout pregnancy. Option A (long duration) correctly identifies a factor that is associated with an increased risk of recurrence. The marked answer (B) did not provide a valid risk factor in the absence of its description, and literature supports that prolonged seizure duration is indeed a predictor of higher recurrence risk. 1. Prolonged seizure duration is a recognized risk factor for future seizure recurrence. 2. A detailed seizure history, including duration, is vital in predicting long-term epilepsy outcomes. 3. Optimizing AED management can reduce the likelihood of recurrence, particularly in patients with risk factors. Recent studies and guidelines continue to confirm that longer-duration seizures contribute to a higher risk of recurrence, thereby underscoring the need for prompt and effective management immediately after the first seizure. This evidence supports revision of the marked answer to option A.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient has focal seizure on treatment and he is well control. What is the favorable outcome in this patient?",
    "option_a": "one type seizure",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question assesses the prognostic significance of seizure type in patients with focal epilepsy that is well controlled on treatment. A patient experiencing only one type of seizure typically has a better prognosis compared to individuals with multiple or evolving seizure types. Epileptogenic networks that give rise to a single, well\u2010defined seizure type suggest a more localized and stable focus of abnormal neuronal activity. In contrast, the presence of multiple seizure types may indicate a more diffuse hyperexcitability or multifocal pathology that is harder to control. Patients with focal epilepsy who experience only one type of seizure and who respond well to antiepileptic therapy are generally more likely to achieve long-term remission. This localized and consistent seizure pattern usually correlates with fewer complications and better overall outcomes. Continuous EEG monitoring, a detailed seizure diary, and neuroimaging help delineate the precise seizure type and its evolution over time. Differential considerations include multifocal epilepsy or secondary generalization, which typically predict a less favorable prognosis. Management aims at maintaining seizure control through appropriate AED monotherapy or combination therapy as needed, with periodic re\u2010evaluation. For women who are pregnant or lactating, AEDs with the best safety profiles in reproduction should be selected, and monotherapy is preferred to limit fetal exposure. Option A (one type seizure) is correct because the presence of a single consistent seizure type in a patient with focal epilepsy suggests a favorable outcome. Multiple seizure types often indicate a broader epileptogenic zone and can be associated with a poorer prognosis. 1. A single, consistent seizure type in focal epilepsy generally predicts a better response to treatment. 2. Achieving and maintaining seizure control is the cornerstone of favorable epilepsy outcomes. 3. Regular follow-up and medication review are essential to sustain long-term remission. Recent research reinforces that patients with well-controlled, monomorphic focal seizures have improved long-term outcomes compared to those with multifocal or evolving seizure patterns. This finding supports the prognostic value of seizure type in clinical practice.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with seizure and mental retardation, EEG showed 2Hz, what is the treatment?",
    "option_a": "valproic acid",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "This question describes a patient with seizures and mental retardation whose EEG shows a 2 Hz spike-and-wave pattern\u2014a classical electrographic hallmark. This presentation is most consistent with Lennox-Gastaut syndrome (LGS), a severe childhood epilepsy characterized by multiple seizure types and cognitive impairment. Lennox-Gastaut syndrome involves widespread cerebral dysfunction with abnormal neuronal networks producing slow (<3 Hz) spike-and-wave discharges on EEG. The underlying mechanisms include genetic predispositions, structural brain abnormalities, and neuroinflammatory processes, contributing to severe, refractory seizures and developmental delays. Patients with LGS typically present with multiple seizure types (often tonic, atonic, and atypical absence seizures), and cognitive impairment is a key clinical feature. The 2 Hz EEG pattern is a diagnostic clue. Early identification is crucial because the syndrome is often resistant to conventional antiepileptic treatment. Diagnosis is based on a combination of clinical history (multiple seizure types, developmental delay), EEG findings (slow spike-and-wave complexes around 2 Hz), and neuroimaging to exclude other structural causes. Differential diagnoses include other epileptic encephalopathies and atypical absence epilepsy; however, the characteristic EEG pattern and clinical deterioration support LGS. Valproic acid is one of the first-line treatments for LGS due to its broad-spectrum efficacy against multiple seizure types. Additional agents include lamotrigine, topiramate, and newer options like rufinamide or clobazam. In refractory cases, dietary therapy (such as the ketogenic diet) or surgical options may be considered. For women of childbearing potential or those who are pregnant/lactating, valproic acid is generally avoided because of its high teratogenic risk; alternatives with a better reproductive safety profile (e.g., lamotrigine or levetiracetam) are recommended. Option A (valproic acid) is correct in many pediatric scenarios; it is a mainstay in the management of LGS despite its limitations. However, in females of childbearing age, caution must be exercised due to teratogenicity. The other options were not provided, but valproic acid remains a traditional first-line agent in this context. 1. Lennox-Gastaut syndrome should be suspected in children with multiple seizure types, cognitive impairment, and a characteristic 2 Hz spike-and-wave EEG pattern. 2. Early aggressive management is crucial to mitigate cognitive decline. 3. When treating women in their reproductive years, alternative agents to valproic acid should be considered. Recent guidelines continue to recognize valproic acid as an effective initial treatment for LGS in pediatric populations, although emerging evidence supports using alternative agents and combination therapies in patients at risk (especially women of childbearing age) due to valproic acid's teratogenic potential. This has led to updated recommendations favoring individualized treatment plans based on patient demographics and risk factors.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with absence seizure; what is the medication worse the seizure:",
    "option_a": "oxycarbazepine",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Absence seizures are a type of generalized seizure characterized by brief episodes of impaired awareness with a characteristic 3 Hz spike\u2010wave pattern on EEG. They are typically treated with agents that enhance GABAergic tone (such as ethosuximide) rather than sodium channel blockers. Medications like oxycarbazepine (similar to carbamazepine) are known to worsen absence seizures by exacerbating thalamocortical network dysregulation. The underlying mechanism involves abnormal oscillatory activity in the thalamocortical circuitry. Sodium channel blockers can inadvertently increase this oscillatory activity in absence epilepsy, thereby worsening seizure control. Recent studies support that drugs which primarily target T-type calcium channels (e.g., ethosuximide) are more effective because they directly modulate the pathological low\u2010threshold calcium spike bursts in thalamic neurons. Patients typically present with brief, sudden lapses in consciousness, often without postictal confusion. The 3 Hz spike-wave EEG pattern is a hallmark. Recognizing that certain medications worsen these seizures is crucial for optimal management. Diagnosis is primarily clinical and confirmed with EEG showing a regular 3 Hz spike-wave pattern. Differential diagnoses include atypical absence seizures (which may have slower, irregular spike-wave complexes) and other causes of brief loss of awareness. A careful history and EEG correlation help differentiate these conditions. First-line therapy is usually ethosuximide in children and adolescents with pure absence seizures. Valproate is an alternative, especially if there is coexisting generalized tonic-clonic activity. It is important to avoid sodium channel blockers like carbamazepine and oxycarbazepine since they can worsen absence seizures. In pregnancy and lactation, ethosuximide and lamotrigine are generally preferred due to lower teratogenic risk. Detailed counseling regarding medication risks and benefits is advised for females of childbearing age. Option A (oxcarbazepine) is correctly identified as a drug that worsens absence seizures. The mechanism relates to its class effect as a sodium channel blocker, which is contraindicated in this seizure type. 1. Absence seizures typically have a 3 Hz spike-wave EEG pattern. 2. Always avoid sodium channel blockers in patients with absence seizures. 3. Ethosuximide remains the first-line treatment for childhood absence epilepsy. Recent guidelines reiterate the importance of using agents that target the thalamocortical circuitry (like ethosuximide) and avoiding sodium channel blockers in absence epilepsy. Studies continue to support the safety profile of ethosuximide in the pediatric population, with careful attention to drug selection in women of childbearing potential.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Male patient has migraine and seizure; what medications you will give?",
    "option_a": "valproic acid",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Absence seizures are a type of generalized seizure characterized by brief episodes of impaired awareness with a characteristic 3 Hz spike\u2010wave pattern on EEG. They are typically treated with agents that enhance GABAergic tone (such as ethosuximide) rather than sodium channel blockers. Medications like oxycarbazepine (similar to carbamazepine) are known to worsen absence seizures by exacerbating thalamocortical network dysregulation. The underlying mechanism involves abnormal oscillatory activity in the thalamocortical circuitry. Sodium channel blockers can inadvertently increase this oscillatory activity in absence epilepsy, thereby worsening seizure control. Recent studies support that drugs which primarily target T-type calcium channels (e.g., ethosuximide) are more effective because they directly modulate the pathological low\u2010threshold calcium spike bursts in thalamic neurons. Patients typically present with brief, sudden lapses in consciousness, often without postictal confusion. The 3 Hz spike-wave EEG pattern is a hallmark. Recognizing that certain medications worsen these seizures is crucial for optimal management. Diagnosis is primarily clinical and confirmed with EEG showing a regular 3 Hz spike-wave pattern. Differential diagnoses include atypical absence seizures (which may have slower, irregular spike-wave complexes) and other causes of brief loss of awareness. A careful history and EEG correlation help differentiate these conditions. First-line therapy is usually ethosuximide in children and adolescents with pure absence seizures. Valproate is an alternative, especially if there is coexisting generalized tonic-clonic activity. It is important to avoid sodium channel blockers like carbamazepine and oxycarbazepine since they can worsen absence seizures. In pregnancy and lactation, ethosuximide and lamotrigine are generally preferred due to lower teratogenic risk. Detailed counseling regarding medication risks and benefits is advised for females of childbearing age. Option A (oxcarbazepine) is correctly identified as a drug that worsens absence seizures. The mechanism relates to its class effect as a sodium channel blocker, which is contraindicated in this seizure type. 1. Absence seizures typically have a 3 Hz spike-wave EEG pattern. 2. Always avoid sodium channel blockers in patients with absence seizures. 3. Ethosuximide remains the first-line treatment for childhood absence epilepsy. Recent guidelines reiterate the importance of using agents that target the thalamocortical circuitry (like ethosuximide) and avoiding sodium channel blockers in absence epilepsy. Studies continue to support the safety profile of ethosuximide in the pediatric population, with careful attention to drug selection in women of childbearing potential.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient came with absence seizure with rare GTC, EEG showed 3Hz, what is the other associated symptoms this patient can have?",
    "option_a": "Eyelid myotonia",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "The question describes a patient with typical absence seizures (characterized by a 3 Hz spike\u2010wave EEG pattern) along with rare generalized tonic\u2013clonic seizures. This clinical picture fits into the spectrum of idiopathic generalized epilepsies \u2013 particularly Juvenile Absence Epilepsy (JAE) \u2013 which can sometimes include myoclonic phenomena. One recognized associated clinical feature in some variants is eyelid myoclonia (often referred to in the literature as 'eyelid myotonia' in some question stems), which is a brief involuntary twitching of the eyelid muscles seen in syndromes like Eyelid Myoclonia with Absences (EMA). Absence seizures result from abnormal oscillations within the thalamocortical network. A disturbance in the interplay between inhibitory (GABAergic) and excitatory (glutamatergic) circuits produces the characteristic 3 Hz spike\u2010wave discharges. In variants where myoclonic features are present, such as eyelid myoclonia, the hyperexcitability may extend to motor areas governing the face, producing rapid, brief contractions. Patients with absence epilepsy typically present with sudden, brief lapses in awareness. While classical childhood absence epilepsy presents with pure staring spells, some patients (especially in the juvenile variant) may develop additional seizure types (rare GTCs and myoclonic jerks). When the motor manifestation involves the eyelids \u2013 seen as eyelid myoclonia \u2013 it points toward a variant (sometimes labeled as EMA) within the generalized epilepsy spectrum. Diagnosis is based on clinical history alongside EEG findings. The classic 3 Hz spike\u2010wave pattern confirms the diagnosis of an absence seizure disorder. It is essential to differentiate these idiopathic generalized epilepsies from others such as Juvenile Myoclonic Epilepsy (which typically shows 4\u20136 Hz polyspike\u2013wave discharges and predominantly involves limb myoclonia) and from focal-onset seizures. Comprehensive evaluation should include an assessment for subtle myoclonic signs (including eyelid movements) through careful video-EEG monitoring. First-line therapy for pure absence seizures is often Ethosuximide; however, in syndromes where there are associated generalized tonic\u2013clonic or myoclonic seizures (as in this patient), Valproic acid is considered the treatment of choice. For women of childbearing potential, the teratogenic risks of Valproate require special consideration. In such cases, alternatives such as Lamotrigine or Levetiracetam may be used although they may be somewhat less effective. During pregnancy and lactation, stringent risk\u2013benefit analysis must be done with appropriate folic acid supplementation and close monitoring, as current guidelines emphasize minimizing in utero exposure to teratogenic medications. Given that the other options were not provided, the available option A ('Eyelid myotonia') is interpreted as referring to eyelid myoclonia \u2013 a clinical sign that can be seen in photosensitive generalized epilepsies and is recognized as an associated feature in a variant of absence epilepsy. In the context described (absence seizures with a 3 Hz pattern and rare GTC), the presence of subtle myoclonic phenomena such as eyelid myoclonia supports the diagnosis, making option A the best answer. \u2022 In a patient with absence seizures (3 Hz spike-wave on EEG) combined with occasional GTC seizures, always consider the broader spectrum of generalized epilepsies (e.g., JAE).\n\u2022 The detection of even subtle myoclonic phenomena, such as eyelid myoclonia, may suggest a variant like EMA.\n\u2022 Treatment decisions must account for the full seizure spectrum and, in women of childbearing age, the risk of medication teratogenicity. Recent clinical guidelines support the use of Valproic acid for generalized epilepsy syndromes that include absence, myoclonic, and generalized tonic\u2013clonic seizures. However, emerging data and updated recommendations highlight the need to avoid Valproate in women of reproductive potential due to its high teratogenic risk. In such scenarios, lamotrigine and levetiracetam are increasingly used, with careful monitoring during pregnancy and lactation. Advances in EEG analysis and video monitoring have improved detection of subtle signs such as eyelid myoclonia, aiding more accurate syndrome classification.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with MTS seizure EEG showed left temporal discharges; what symptoms he has?",
    "option_a": "Left automatism",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "Mesial temporal sclerosis (MTS) typically gives rise to temporal lobe epilepsy which is characterized by complex partial seizures. These seizures usually begin with a subjective aura and progress to impaired awareness accompanied by stereotyped, repetitive behaviors known as automatisms. In MTS, hippocampal sclerosis leads to neuronal loss and gliosis in mesial temporal structures (including the hippocampus and amygdala), which generates hyperexcitability and synchronized epileptiform discharges. The aberrant electrical activity is captured on EEG as temporal discharges, localizing the epileptogenic focus. Patients with left MTS (especially in left\u2010dominant individuals) often experience auras, such as epigastric rising sensations or d\u00e9j\u00e0 vu, followed by impaired awareness and automatisms (e.g., lip smacking, fumbling with hands). Although automatisms themselves are not reliably lateralizing, in the context of a left temporal focus the clinical picture supports temporal lobe seizure semiology. Diagnosis relies on a combination of clinical history, video-EEG monitoring, and high-resolution MRI. When MRI findings are subtle or negative, additional imaging (such as PET or SPECT) may be considered to further localize the epileptogenic zone. Initial management is with anti-seizure medications (e.g., carbamazepine, levetiracetam) with careful consideration of drug side effects. For drug-resistant cases, surgical options such as anterior temporal lobectomy are indicated. In pregnancy and lactation, medications with lower teratogenic risk are preferred, and folic acid supplementation should be provided to minimize teratogenicity. Option A, 'Left automatism', is chosen because temporal lobe seizures typically feature automatisms. Although these behaviors (such as lip smacking or hand fumbling) are not consistently lateralized, the context of left temporal discharges supports that the patient exhibits the typical complex partial seizure pattern seen in MTS. 1. Mesial temporal lobe epilepsy often presents with an aura followed by complex partial seizures with automatisms. 2. MRI and EEG findings are key in confirming the diagnosis of MTS, with automation behaviors being a classic clinical sign. Recent studies emphasize the value of high-resolution MRI for detecting mesial temporal sclerosis and advocate for multimodality evaluation (including functional imaging in select cases) to optimize surgical candidacy in patients with drug\u2010resistant epilepsy.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Most common type of aura in MTL seizure?",
    "option_a": "(visceral/epigastric rising sensation aura) is correct. Other possible auras (visual, auditory, somatosensory) are less common in mesial temporal seizures and are more typically seen in seizures originating from other cortical regions.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "An aura represents the initial manifestation of a seizure, signaling focal neuronal discharge. In mesial temporal lobe epilepsy, the involvement of limbic and autonomic structures commonly produces visceral or epigastric sensations. The mesial temporal structures, particularly the hippocampus and amygdala, are closely linked to autonomic control. Ictal discharges in these regions can cause abnormal sensory perceptions, notably the epigastric rising sensation, due to their role in visceral sensation and emotional processing. Patients with mesial temporal lobe seizures frequently report a characteristic visceral or epigastric aura\u2014often described as a rising sensation in the stomach\u2014before progressing to the impaired awareness and automatisms typical of complex partial seizures. A detailed history emphasizing the type and sequence of symptoms is pivotal. Correlation with video-EEG and imaging studies confirms the diagnosis. Differential considerations include auras from neocortical seizures, which may manifest as visual or auditory phenomena. Management focuses on seizure control through anti-seizure medications as first-line therapy. For candidates with drug-resistant MTLE, surgical evaluation may be warranted. In pregnant or lactating patients, selection of ASM that have better safety profiles during pregnancy is essential, along with folic acid supplementation. Option A (visceral/epigastric rising sensation aura) is correct. Other possible auras (visual, auditory, somatosensory) are less common in mesial temporal seizures and are more typically seen in seizures originating from other cortical regions. 1. The epigastric aura is nearly pathognomonic for mesial temporal lobe epilepsy. 2. A thorough history of auras greatly aids in localizing the seizure onset zone. Current clinical guidelines and research underscore the prevalence of the epigastric aura in MTLE, with numerous studies linking this clinical feature to limbic system involvement and supporting its role in seizure classification and surgical planning.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "MTS seizure with normal MRI, EEG showed right frontotemporal discharge; next step?",
    "option_a": "Scalp EEG",
    "option_b": "interictal PET",
    "option_c": "interictal SPECT",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Epilepsy",
    "explanation": "In epilepsy evaluation, especially in drug-resistant cases, combining structural imaging (MRI) with functional imaging is crucial. When MRI is normal but clinical and EEG evidence suggests an epileptogenic focus, further localization using metabolic studies is indicated. Epileptogenic regions demonstrate altered metabolism. In interictal FDG-PET imaging, the seizure focus typically appears as an area of hypometabolism, reflecting chronic neuronal dysfunction stemming from repeated ictal events. A patient with a diagnosis of MTS and a normal MRI but with right frontotemporal EEG discharges represents a scenario where structural imaging is inconclusive. In such cases, identifying the metabolic abnormality with interictal PET helps confirm the seizure focus, which is pivotal in planning further management, including potential surgical intervention. Initial evaluation includes scalp EEG and high-resolution MRI. When MRI does not reveal a lesion, functional imaging techniques such as interictal FDG-PET or ictal/interictal SPECT are used. PET has become the modality of choice in many centers for MRI-negative epilepsy workups due to its sensitivity in detecting hypometabolic zones. The first-line management remains optimized anti-seizure medications; however, in candidates for epilepsy surgery, precise localization by FDG-PET is critical. In pregnancy, while imaging with PET involves radiation exposure, the risks and benefits must be carefully weighed; typically, such evaluations are deferred until after delivery unless urgently needed. Option B, interictal PET, is correct because it enables the detection of hypometabolism in the epileptogenic cortex even when MRI is normal. Option A (repeat scalp EEG) would not provide additional localizing information, and Option C (interictal SPECT) is less sensitive in the interictal phase compared to PET, with ictal SPECT being more informative when timed correctly. 1. FDG-PET is a valuable tool in localizing seizure foci in MRI-negative epilepsy. 2. Functional imaging should be considered when there is a discrepancy between clinical/EEG findings and structural imaging. Recent guidelines and studies have reinforced the use of FDG-PET in the evaluation of MRI-negative epilepsies. Its ability to detect hypometabolic areas correlates well with the epileptogenic zone, thereby aiding in surgical decision-making and improving patient outcomes.",
    "exam_year": "2021",
    "exam_type": "Part II"
  },
  {
    "question": "Most common cause of SUDEP:",
    "option_a": "uncontrolled seizure.",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Epilepsy",
    "explanation": "SUDEP (Sudden Unexpected Death in Epilepsy) is a phenomenon where patients with epilepsy die suddenly without a clear structural or toxicological cause. The risk is most pronounced in individuals with poorly controlled or frequent generalized seizures. The underlying mechanisms of SUDEP likely involve a combination of cardiac arrhythmias, respiratory dysfunction, and autonomic dysregulation that occur during or immediately after a seizure, particularly generalized tonic-clonic seizures. Uncontrolled seizures increase the likelihood of such fatal events. Clinically, patients with uncontrolled seizures, especially those with frequent generalized tonic-clonic events, are at a significantly higher risk of SUDEP. This underscores the critical importance of achieving optimal seizure control to mitigate this risk. Risk stratification in epilepsy involves assessing seizure frequency, treatment adherence, and comorbid conditions. While there is no definitive diagnostic test for SUDEP, thorough clinical evaluation can help identify high-risk individuals, prompting more aggressive management strategies. The primary strategy for preventing SUDEP is the stringent control of seizures through anti-seizure medications. For patients with drug-resistant epilepsy, surgical options or neuromodulation can be considered. In pregnant or lactating women, maintaining seizure control is paramount, and medications with lower teratogenic risk should be prioritized, along with close monitoring throughout the perinatal period. Option A, 'uncontrolled seizure,' is correct because it reflects the most significant risk factor for SUDEP. Numerous studies have shown a strong association between uncontrolled generalized tonic-clonic seizures and increased SUDEP risk. Other potential risk modifiers (e.g., medication noncompliance or comorbidities) ultimately tie back to seizure control. 1. Achieving and maintaining seizure control is essential for reducing the risk of SUDEP. 2. Patients with frequent generalized tonic-clonic seizures should be counseled on the importance of medication adherence and lifestyle modifications. Contemporary research and meta-analyses consistently identify uncontrolled generalized tonic-clonic seizures as the strongest risk factor for SUDEP. Updated clinical guidelines reinforce aggressive seizure management and highlight the need for individualized risk reduction strategies.",
    "exam_year": "2021",
    "exam_type": "Part II"
  }
]